Moderna Stock Falls
Moderna Inc (NASDAQ:MRNA) shares are trading lower Wednesday after Goldman Sachs downgraded the stock. Here's what you need ...
In a report released today, Tyler Van Buren from TD Cowen maintained a Hold rating on Moderna (MRNA – Research Report), with a price target of ...
Vaccine manufacturer Moderna has welcomed the Chancellor's announcements regarding major infrastructure schemes.
The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health ...
At the healthcare conference, Moderna lowered expected 2025 revenue to the range of $1.5 billion to $2.5 billion -- down from ...
The US Department of Health and Human Services awarded Moderna $590 million to continue developing a vaccine to protect against bird flu.
The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...
10don MSN
While the headline numbers don't inspire much confidence, Moderna is a stock that deserves a closer look. The company still ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback